Close Menu

NEW YORK – NeoGenomics announced Monday that it has been awarded a three-year contract to serve as the cornerstone laboratory for HealthTrust Purchasing Group's Specialized Reference Laboratory for Oncology & Cancer Genetics.

Financial and other terms of the deal were not disclosed.

The agreement, which went into effect March 1, secures standardized corporate pricing for HPG-affiliated facilities and providers across the US and provides access to NeoGenomics' cancer diagnostic and oncology genetics testing services.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.